PMID- 34848742 OWN - NLM STAT- MEDLINE DCOM- 20220124 LR - 20220124 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 11 IP - 1 DP - 2021 Nov 30 TI - Endogenous regulation of the Akt pathway by the aryl hydrocarbon receptor (AhR) in lung fibroblasts. PG - 23189 LID - 10.1038/s41598-021-02339-3 [doi] LID - 23189 AB - The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor known to mediate toxic responses to dioxin. However, the role of the AhR in the regulation of cellular physiology has only recently been appreciated, including its ability to control cell cycle progression and apoptosis by unknown mechanisms. We hypothesized that the AhR enhances the activation of the AKT serine/threonine kinase (Akt) pathway to promote cell survival. Utilizing AhR knock-out (Ahr(-/-)) and wild-type (Ahr(+/+)) mouse lung fibroblasts (MLFs), we found that Ahr(-/-) MLFs have significantly higher basal Akt phosphorylation but that AhR did not affect Akt phosphorylation in MLFs exposed to growth factors or AhR ligands. Basal Akt phosphorylation was dependent on PI3K but was unaffected by changes in intracellular glutathione (GSH) or p85alpha. There was no significant decrease in cell viability in Ahr(-/-) MLFs treated with LY294002-a PI3K inhibitor-although LY294002 did attenuate MTT reduction, indicating an affect on mitochondrial function. Using a mass spectrometry (MS)-based approach, we identified several proteins that were differentially phosphorylated in the Ahr(-/-) MLFs compared to control cells, including proteins involved in the regulation of extracellular matrix (ECM), focal adhesion, cytoskeleton remodeling and mitochondrial function. In conclusion, Ahr ablation increased basal Akt phosphorylation in MLFs. Our results indicate that AhR may modulate the phosphorylation of a variety of novel proteins not previously identified as AhR targets, findings that help advance our understanding of the endogenous functions of AhR. CI - (c) 2021. The Author(s). FAU - Shi, Fangyi AU - Shi F AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. AD - Department of Pathology, McGill University, Montreal, QC, Canada. FAU - Aloufi, Noof AU - Aloufi N AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. AD - Department of Pathology, McGill University, Montreal, QC, Canada. FAU - Traboulsi, Hussein AU - Traboulsi H AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. AD - Department of Medicine, McGill University, Montreal, QC, Canada. FAU - Trempe, Jean-Francois AU - Trempe JF AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. AD - Department of Pharmacology & Therapeutics, McGill University, Montreal, QC, Canada. FAU - Eidelman, David H AU - Eidelman DH AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. AD - Department of Medicine, McGill University, Montreal, QC, Canada. FAU - Baglole, Carolyn J AU - Baglole CJ AD - Research Institute of the McGill University Health Centre, Montreal, QC, Canada. Carolyn.baglole@mcgill.ca. AD - Department of Pathology, McGill University, Montreal, QC, Canada. Carolyn.baglole@mcgill.ca. AD - Department of Medicine, McGill University, Montreal, QC, Canada. Carolyn.baglole@mcgill.ca. AD - Department of Pharmacology & Therapeutics, McGill University, Montreal, QC, Canada. Carolyn.baglole@mcgill.ca. LA - eng GR - PJT-168836/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211130 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Receptors, Aryl Hydrocarbon) RN - 0 (Smoke) RN - 0 (Tetrazolium Salts) RN - 0 (Thiazoles) RN - EC 2.7.11.1 (Akt1 protein, mouse) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EUY85H477I (thiazolyl blue) SB - IM MH - Animals MH - Cell Survival MH - Cells, Cultured MH - Cytoskeleton MH - Fibroblasts/metabolism MH - *Gene Expression Regulation MH - Homeostasis MH - Intercellular Signaling Peptides and Proteins MH - Lung/*metabolism MH - Mass Spectrometry MH - Mice MH - Phosphorylation MH - Proteomics/methods MH - Proto-Oncogene Proteins c-akt/*biosynthesis MH - Receptors, Aryl Hydrocarbon/*metabolism MH - Smoke MH - Tetrazolium Salts/pharmacology MH - Thiazoles/pharmacology MH - Tobacco Products PMC - PMC8632926 COIS- The authors declare no competing interests. EDAT- 2021/12/02 06:00 MHDA- 2022/01/27 06:00 PMCR- 2021/11/30 CRDT- 2021/12/01 06:17 PHST- 2021/03/17 00:00 [received] PHST- 2021/11/08 00:00 [accepted] PHST- 2021/12/01 06:17 [entrez] PHST- 2021/12/02 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2021/11/30 00:00 [pmc-release] AID - 10.1038/s41598-021-02339-3 [pii] AID - 2339 [pii] AID - 10.1038/s41598-021-02339-3 [doi] PST - epublish SO - Sci Rep. 2021 Nov 30;11(1):23189. doi: 10.1038/s41598-021-02339-3.